Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global BPH Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Treatment (Alpha Blockers, 5-Alpha Reductase Inhibitors, and Phosphodiesterase-5 Inhibitors)
5.2.2. By Surgical Treatment (Transurethral resection of the prostate (TURP), Prostatic Urethral Lift (PUL), Prostatectomy, laser surgery, Transurethral microwave Technique (TUMT), Transurethral needle ablation of the prostate (TUNA), and others (Rezum therapy, Urolift therapy, etc)
5.2.3. By End User (hospitals and clinics, ambulatory surgical centres, and Others)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Drug Treatment
5.3.2. By Surgical Treatment
5.3.3. By End User
5.3.4. By Region
6. North America BPH Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Treatment
6.2.2. By Surgical Treatment
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States BPH Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Treatment
6.3.1.2.2. By Surgical Treatment
6.3.1.2.3. By End User
6.3.2. Canada BPH Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Treatment
6.3.2.2.2. By Surgical Treatment
6.3.2.2.3. By End User
6.3.3. Mexico BPH Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Treatment
6.3.3.2.2. By Surgical Treatment
6.3.3.2.3. By End User
7. Europe BPH Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Treatment
7.2.2. By Surgical Treatment
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France BPH Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Treatment
7.3.1.2.2. By Surgical Treatment
7.3.1.2.3. By End User
7.3.2. Germany BPH Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Treatment
7.3.2.2.2. By Surgical Treatment
7.3.2.2.3. By End User
7.3.3. United Kingdom BPH Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Treatment
7.3.3.2.2. By Surgical Treatment
7.3.3.2.3. By End User
7.3.4. Italy BPH Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Treatment
7.3.4.2.2. By Surgical Treatment
7.3.4.2.3. By End User
7.3.5. Spain BPH Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Treatment
7.3.5.2.2. By Surgical Treatment
7.3.5.2.3. By End User
8. Asia-Pacific BPH Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Treatment
8.2.2. By Surgical Treatment
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China BPH Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Treatment
8.3.1.2.2. By Surgical Treatment
8.3.1.2.3. By End User
8.3.2. Japan BPH Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Treatment
8.3.2.2.2. By Surgical Treatment
8.3.2.2.3. By End User
8.3.3. India BPH Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Treatment
8.3.3.2.2. By Surgical Treatment
8.3.3.2.3. By End User
8.3.4. South Korea BPH Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Treatment
8.3.4.2.2. By Surgical Treatment
8.3.4.2.3. By End User
8.3.5. Australia BPH Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Treatment
8.3.5.2.2. By Surgical Treatment
8.3.5.2.3. By End User
9. South America BPH Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Treatment
9.2.2. By Surgical Treatment
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil BPH Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Treatment
9.3.1.2.2. By Surgical Treatment
9.3.1.2.3. By End User
9.3.2. Argentina BPH Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Treatment
9.3.2.2.2. By Surgical Treatment
9.3.2.2.3. By End User
9.3.3. Colombia BPH Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Treatment
9.3.3.2.2. By Surgical Treatment
9.3.3.2.3. By End User
10. Middle East and Africa BPH Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Treatment
10.2.2. By Surgical Treatment
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. UAE BPH Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Treatment
10.3.1.2.2. By Surgical Treatment
10.3.1.2.3. By End User
10.3.2. Saudi Arabia BPH Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Treatment
10.3.2.2.2. By Surgical Treatment
10.3.2.2.3. By End User
10.3.3. South Africa BPH Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Treatment
10.3.3.2.2. By Surgical Treatment
10.3.3.2.3. By End User
10.3.4. Turkey BPH Treatment Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Drug Treatment
10.3.4.2.2. By Surgical Treatment
10.3.4.2.3. By End User
10.3.5. Egypt BPH Treatment Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Drug Treatment
10.3.5.2.2. By Surgical Treatment
10.3.5.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.1.1. Increasing prevalence of Benign Prostate Hyperplasia
11.1.2. Growing geriatric population
11.1.3. Technological Advancement
11.2. Challenges
11.2.1. High Cost of Procedure
11.2.2. Side effects associated with the technique
11.2.3. Lack of Skilled Professionals to conduct invasive surgeries
12. Market Trends & Developments
12.1. Development of new drugs
12.2. Development of new surgeries
13. Clinical Trial Analysis
13.1. Ongoing Clinical Trials
13.2. Completed Clinical Trials
13.3. Terminated Clinical Trials
13.4. Breakdown of Pipeline, By Development Phase
13.5. Breakdown of Pipeline, By Status
13.6. Breakdown of Pipeline, By Study Type
13.7. Breakdown of Pipeline, By Region
13.8. Clinical Trials Heat Map
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (In Case of Listed Companies)
14.5. Key Personnel
14.5.1. Boston Scientific Corporation
14.5.2. Coloplast Corporation
14.5.3. Teleflex Incorporated
14.5.4. Olympus Corporation
14.5.5. Glaxo Smith Kline PLC
14.5.6. Eli Lily
14.5.7. Abott Laboratories
14.5.8. Medifocus Inc.
14.5.9. Urologix, LLC
14.5.10. Pfizer Inc
15. Strategic Recommendations
16. About Us and Disclaimer